Home The Cluster Members R & D [Publications] Meetings Contact
    Publications

Sandra A. Calarota, Anlan Daic, Jeffrey N. Trocio, David B.Weiner, Franco Lori, Julianna Lisziewicz
IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine
ELSEVIER, Vaccine, 2008

Lisziewicz J, Calarota SA, Lori F.
The potential of topical DNA vaccines adjuvanted by cytokines.
Expert Opin Biol Ther. 2007 Oct;7(10):1563-74. Review.

Lori F, Calarota SA, Lisziewicz J.
Nanochemistry-based immunotherapy for HIV-1.
Curr Med Chem. 2007;14(18):1911-9. Review.

Cristillo AD, Lisziewicz J, He L, Lori F, Galmin L, Trocio JN, Unangst T, Whitman L, Hudacik L, Bakare N, Whitney S, Restrepo S, Suschak J, Ferrari MG, Chung HK, Kalyanaraman VS, Markham P, Pal R.
HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.
Virology. 2007 Sep 15;366(1):197-211. Epub 2007 May 11.

Calarota SA, Weiner DB, Lori F, Lisziewicz J.
Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.
Vaccine. 2007 Apr 20;25(16):3070-4. Epub 2007 Jan 22.

Lori F, Weiner DB, Calarota SA, Kelly LM, Lisziewicz J.
Cytokine-adjuvanted HIV-DNA vaccination strategies.
Springer Semin Immunopathol. 2006 Nov;28(3):231-8. Epub 2006 Oct 20. Review.

Xu JQ, Lori F, Lisziewicz J.
CD4+ T cell-mediated presentation of non-infectious HIV-1 virion antigens to HIV-specific CD8+ T cells.
Chin Med J (Engl). 2006 Oct 5;119(19):1629-38.

Lisziewicz, J., L. Kelly, and F. Lori,
Topical DermaVir vaccine targeting dendritic cells.
Curr Drug Deliv, 2006. 3(1): p. 83-8.

Lori, F., et al.,
Cytokine-adjuvanted HIV-DNA vaccination strategies.
Springer Semin Immunopathol, 2006. 28(3): p. 231-8.

Xu, J.Q., F. Lori, and J. Lisziewicz,
CD4+ T cell-mediated presentation of non-infectious HIV-1 virion antigens to HIV-specific CD8+ T cells.
Chin Med J (Engl), 2006. 119(19): p. 1629-38.

Lori F, Trocio J, Bakare N, Kelly LM, Lisziewicz J. (2005).
"DermaVir, a novel HIV immunisation technology".
Vaccine; 23(17-18):2030-4.

Lisziewicz J, Trocio J, Whitman L, Varga G, Xu J, Bakare N, Erbacher P, Fox C, Woodward R, Markham P, Arya S, Behr JP, Lori F. (2005).
"DermaVir: a novel topical vaccine for HIV/AIDS".
J Invest Dermatol;124(1):160-9.

Lisziewicz J, Trocio J, Xu J, Whitman L, Ryder A, Bakare N, Lewis MG, Wagner W, Pistorio A, Arya S, Lori F. (2005).
"Control of viral rebound through therapeutic immunization with DermaVir".
AIDS; 19(1):35-43.

Lori F, Kelly LM, Lisziewicz J. (2004).
"APC-targeted immunization for the treatment of HIV-1".
Expert Rev Vaccines; 3:S189-98.

Xu J, Lori F, Lisziewicz J. (2003).
"Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytes".
J Immunol Methods; 276(1-2):45-57.

Lisziewicz J, Bakare N, Lori F. (2003).
"Therapeutic vaccination for future management of HIV/AIDS".
Vaccine; 21(7-8):620-3.

Lori F, Kelly LM, Lisziewicz J. (2003).
"Immunological approaches for HIV therapy".
Curr Drug Targets Infect Disord; 3(2):171-8.




Contents © 2009 NanoMedicine Cluster. Created by L&Mark Informatika Kft.